13 14 15 16 Experimental uses small 40 people 10-week, double-blind clinical trial was reported in the Journal of Clinical Psychiatry on the effectiveness of atomoxetine for treating binge eating disorder. The symptoms must be persistent, must be more severe than is typically observed in individuals at comparable level of development, must cause clinically significant impairment,. The following reactions were reported by at least of patients treated with atomoxetine, and equal to or less than placebo: pharyngolaryngeal pain, insomnia insomnia includes the terms, insomnia, initial insomnia, middle insomnia. Although causal link between the emergence of such symptoms and the emergence of suicidal impulses has not been established, there is concern that such symptoms atomoxetine shipped cod on saturday delivery may represent precursors to emerging suicidality. The other study authors have disclosed no relevant financial relationships. This is not complete list of side effects and others may occur. Consideration should be given to not treating adults with clinically significant cardiac abnormalities.
Full article